February 2009 Editor's Picks: Products from Oystar USA and Schreiner MediPharm - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

February 2009 Editor's Picks: Products from Oystar USA and Schreiner MediPharm


Equipment and Processing Report

Featured products from Pharmaceutical Technology's monthly newsletter, Equipment & Processing Report

product Oystar USA
Press produces multilayer tablets

Oystar USA (Fairfield, NJ) offers its “FlexiTab” fully automated, single-station tablet press for small-batch production. The machine features a multilayer-tablet function to produce three-layer tablets.

The FlexiTab device is not fixed to a compression cycle, unlike other tablet presses. Parameters such as tablet weight, force, dwell, and thickness are adjustable through the unit’s touch-screen panel control system. The press’s hydraulic and pneumatic cylinders achieve compression forces as great as 100 kN and enable rapid punch displacement. Operators can thus simulate various rotary tablet presses at various speeds.

In addition to enabling the compression cycle to be modified, the FlexiTab unit’s computer and software can store compression-profile and tooling-list data. The machine uses standard Euro B and D tooling and can be operated in setup, series, step-by-step, and manual modes.



productSchreiner MediPharm
Label system helps prevent injuries

The “Needle-Trap” system from Schreiner MediPharm (Blauvelt, NY) is a label for disposable syringes designed to protect healthcare providers from accidental needlestick injuries. The system comprises a self-adhesive syringe label with an integrated safety mechanism that secures the needle. Healthcare providers can easily uncover the needle to deliver an injection and secure it afterward, without altering their injection technique.

The Needle-Trap labels can be incorporated into common pharmaceutical labeling systems easily. The product is also available with optional detachable documentation labels intended to reduce the risk of medication errors. The labels can be adapted to the most common syringe types.

The system’s easy integration, flexibility, and process reliability make it a suitable solution for pharmaceutical manufacturers, according to the company. In addition, the Needle-Trap system meets healthcare professionals’ requirements for field-use safety.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
13%
To select process for new products only
24%
To select processes for both new and legacy products
20%
Do not use QbD
22%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Equipment and Processing Report,
Click here